From the announcement. Doesn't look like it.
The Company will continue its manufacturing of the Patch at its wholly owned R&D facilities in Israel and also via an FDA and ISO certified medical device contract manufacturer in Israel, ahead of future production at G Medical’s
Guangzhou China production facility.
GMV Price at posting:
7.2¢ Sentiment: Hold Disclosure: Held